John Neoptolemos News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Phase I study showed good safety profile, no dose-limiting toxicities, and encouraging activity

Baden wübergUnited statesJohn neoptolemosChristoph springfeldMike bassettGastroenterol hepatolHeidelberg university hospitalAndrew deanGod subiaco hospitalLancet gastroenterology